| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |